OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Project:
Therapeutic drug monitoring
Categories:
Operational efficiencies
Clinical outcomes
Observational
6 Publications
found
Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
b
Inflammatory intestinal diseases
January 1, 2022
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Economics
Observational
Operational efficiencies
Patient-centeredness
Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results.
b
Inflammatory intestinal diseases
September 1, 2021
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Observational
Operational efficiencies
A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease.
b
British journal of clinical pharmacology
June 1, 2020
p
Therapeutic drug monitoring
c
Clinical outcomes
Highlighted
Observational
Operational efficiencies
Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease.
b
Inflammatory bowel diseases
January 6, 2020
p
Therapeutic drug monitoring
c
Clinical outcomes
Observational
Operational efficiencies
Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study.
b
Biologics : targets & therapy
January 1, 2020
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Observational
Operational efficiencies
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.
b
Journal of Crohn's & colitis
August 29, 2018
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Observational
Operational efficiencies
